1. Home
  2. EVN vs FLGT Comparison

EVN vs FLGT Comparison

Compare EVN & FLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance Municipal Income Trust

EVN

Eaton Vance Municipal Income Trust

HOLD

Current Price

$10.31

Market Cap

430.6M

Sector

Finance

ML Signal

HOLD

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$15.94

Market Cap

511.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVN
FLGT
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
430.6M
511.2M
IPO Year
1998
2016

Fundamental Metrics

Financial Performance
Metric
EVN
FLGT
Price
$10.31
$15.94
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$28.33
AVG Volume (30 Days)
72.4K
797.5K
Earning Date
01-01-0001
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$18,730,000.00
Revenue This Year
N/A
$10.09
Revenue Next Year
N/A
$12.18
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.59
$13.46
52 Week High
$11.23
$31.04

Technical Indicators

Market Signals
Indicator
EVN
FLGT
Relative Strength Index (RSI) 33.52 39.64
Support Level $10.27 $13.46
Resistance Level $11.15 $22.48
Average True Range (ATR) 0.13 0.57
MACD -0.06 0.44
Stochastic Oscillator 26.17 65.50

Price Performance

Historical Comparison
EVN
FLGT

About EVN Eaton Vance Municipal Income Trust

Eaton Vance Municipal Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax. The trust's portfolio of investments majorly consists of debt instruments of governments, municipal organizations the interest on which is exempt from regular federal income tax and has also some exposure to corporate bonds and other instruments.

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

Share on Social Networks: